Latest News

Friday, May 06, 2016 | Product Releases, Clarity Medical Systems

Clarity Medical Systems Announces Major Update to HOLOS IntraOp System

Clarity Medical Systems announced the pending release of the HOLOS Barrett Intraocular Lens Formula, which will be available exclusively on the HOLOS IntraOp Wavefront Aberrometer in mid-2016. Develop…

Read the full story

Friday, May 06, 2016 | Earnings & Financials, Allergan

Teva Pharm Finalizing Asset Sales to Clear Allergan Deal: Source

Teva Pharmaceutical Industries Ltd is finalizing as much as $2 billion in asset sale agreements to win U.S. antitrust clearance for its $40.5 billion acquisition of Allergan Plc's generic drug por…

Read the full story

Friday, May 06, 2016 | Product Releases

Surgical Specialties to Showcase Growing Family of Sharpoint Ophthalmic Instruments at ASCRS

Surgical Specialties will showcase its growing family of Sharpoint products, including single-use surgical instruments at the upcoming American Society of Cataract and Refractive Surgeons (ASCRS) meet…

Read the full story

Friday, May 06, 2016 | Conferences, Retina, Alimera Sciences

Alimera Sciences' Iluvien Data Presented at ARVO

Alimera Sciences announced that data from seven Iluvien post marketing studies were presented during the 2016 Annual Meeting of the Association for Research in Vision and Ophthalmology (ARVO) in Seatt…

Read the full story

Friday, May 06, 2016 | Blindness, Clinical Trials

Device Work on Eyeglasses Offers Hope for People with Low Vision

A miniature camera using optical character-recognition technology, mounted onto the eyeglasses of people who are considered legally blind, dramatically improves their ability to read an email, newspap…

Read the full story

Friday, May 06, 2016 | Product Releases

Surgilum Introduces First Self-Illuminating Photon Speculum

Surgilum introduced the Photon Speculum, the first self-illuminating eyespeculum, at the ASCRS meeting. The product is made up of a single-use corneal transilluminator that magnetically attaches to th…

Read the full story

Friday, May 06, 2016 | Clinical Trials

Encore Vision Announces Successful Phase 1-2 Study of Topical EV06 for the Treatment of Presbyopia

Encore Vision presented positive results during the Ophthalmic Innovation Summit from their phase 1-2 study evaluating the safety and efficacy of EV06 ophthalmic solution 1.5%. EV06 is a novel topical…

Read the full story

Thursday, May 05, 2016 | Product Releases, Haag Streit, Reliance Medical Products

Reliance Medical Products Launches I-OPS In-Office Procedure System at ASCRS

Reliance Medical Products and Haag-Streit USA announced the launch of the I-OPS In-Office Procedure System at the ASCRS meeting in New Orleans, according to a company news release. Developed in col…

Read the full story

Thursday, May 05, 2016 | Conferences, Abbott Medical Optics, AMO

Abbott to Host 20th Anniversary AMO University Event

On Friday, May 6, Abbott Medical Optics will host AMO University, which marks it's 20th anniversary this year. The 20th anniversary AMO University event is all about harnessing possibility to empo…

Read the full story

Thursday, May 05, 2016 | Dry Eye, Product Releases, TearScience

TearScience Introduces LipiScan for Rapid High-Definition Meibomian Imaging

TearScience announced the release of LipiScan, the first dedicated high-definition gland imager that allows eye care professionals to assess meibomian gland structure during routine workups in a pract…

Read the full story

Thursday, May 05, 2016 | Clinical Trials, Dry Eye, Lumenis Vision

Lumenis to Present Interim Safety and Efficacy Results of IPL with OPT for Treating Dry Eye at ASCRS

Lumenis will present interim results of a multicenter, prospective clinical trial designed to study the safety and efficacy of Optimal Pulse Technology (OPT), the next generation of Intense Pulse Ligh…

Read the full story

Thursday, May 05, 2016 | Partnerships

Refractive Surgery Alliance Society (RSA) Announces Membership in the American Refractive Surgery Council (ARSC)

Refractive Surgery Alliance Society (RSA), a professional organization comprised refractive and cataract surgeons, announced it has joined the American Refractive Surgery Council (ARSC), a worki…

Read the full story

Thursday, May 05, 2016 | Clinical Trials, Aerie Pharmaceuticals

Aerie Pharmaceuticals Completes Enrollment of Mercury 1 Phase 3 Registration Trial of Roclatan

Aerie Pharmaceuticals announced the completion of patient enrollment in the company’s initial phase 3 registration trial (Mercury 1) of Roclatan (netarsudil/latanoprost ophthalmic solution) 0.02…

Read the full story

Thursday, May 05, 2016 | Medical Studies

New Method Could Offer More Precise Treatment for Corneal Disease

Researchers have developed a new light-based technique that selectively stiffens tissue in the cornea and might one day offer improved treatment for eye problems caused by weakened corneal tissue, acc…

Read the full story

Thursday, May 05, 2016 | Earnings & Financials, TearLab Corp.

TearLab Announces $17.3 Million Public Offering

TearLab announced May 4, 2016, the pricing of a public offering of the company’s common stock, resulting in total gross proceeds of approximately $17.3 million. The offering is expected to close…

Read the full story
Load More
 Stock Price  Change 
 Aerie Pharmaceuticals, Inc. $13.44  -7.44% 
 Akorn, Inc. $22.00  -7.87% 
 Alimera Sciences, Inc. $1.86  -3.12% 
 Allergan $201.65  -4.13% 
 Avalanche Biotechnologies $4.14  -14.29% 
 Bayer $112.01  0.23% 
 Can-Fite Biopharma $2.73  5.17% 
 Carl Zeiss Meditec $29.63  -0.10% 
 Cooper Companies, Inc. $153.31  -0.25% 
 Eleven Biotherapeutics $0.94  -8.74% 
 Escalon Medical Corp. $0.73  -2.67% 
 Essilor International $127.50  0.00% 
 Glaukos $23.03  -2.00% 
 Imprimis Pharmaceuticals, Inc. $3.70  -0.80% 
 Inotek Pharmaceuticals $10.42  0.48% 
 InSite Vision, Inc. $0.35  0.00% 
 IRIDEX Corporation $11.09  -8.46% 
 Johnson & Johnson $112.74  -0.12% 
 Luxottica Group, S.p.A. $55.78  -0.41% 
 Merck & Company, Inc. $53.60  -0.91% 
 NicOx $8.20  2.36% 
 NovaBay Pharmaceuticals, Inc. $2.16  -10.00% 
 Novartis AG Common Stock $73.05  -1.44% 
 Ocular Therapeutix $10.16  -3.42% 
 Ophthotech Corporation $42.64  -1.91% 
 QLT $1.51  0.00% 
 Quantel $3.54  -0.84% 
 Regeneron $369.95  -2.06% 
 Roche $30.26  -1.43% 
 Second Sight Medical Products $4.07  0.00% 
 Shire $173.80  -1.19% 
 STAAR Surgical Company $7.32  -3.05% 
 TearLab Corporation $0.85  2.42% 
 Thrombogenics $3.70  0.00% 
 Topcon Corporation $9.53  -4.41% 
 TriVascular Technologies, Inc. $5.87  0.00% 
 Valeant Pharmaceuticals $29.89  -13.34% 
 Xoma $0.72  -2.34%